Cygnal Therapeutics Revenue and Competitors

Boston, MA USA

Location

$65M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cygnal Therapeutics's estimated annual revenue is currently $1.6M per year.(i)
  • Cygnal Therapeutics's estimated revenue per employee is $77,500
  • Cygnal Therapeutics's total funding is $65M.

Employee Data

  • Cygnal Therapeutics has 20 Employees.(i)
  • Cygnal Therapeutics grew their employee count by -9% last year.

Cygnal Therapeutics's People

NameTitleEmail/Phone
1
SVP, IP & Legal AffairsReveal Email/Phone
2
Senior Researcher Associate at TherapeuticsReveal Email/Phone
3
Co-op Research AssociateReveal Email/Phone
4
Senior Research AssociateReveal Email/Phone
5
Senior Scientist, immuno-oncologyReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Research AssistantReveal Email/Phone
8
Research AssistantReveal Email/Phone
9
Senior Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Cygnal Therapeutics?

Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platformᅢᄁ¬ダᅡᄁ, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.

keywords:N/A

$65M

Total Funding

20

Number of Employees

$1.6M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M20-5%N/A
#2
$5M20-23%N/A
#3
$2M20N/AN/A
#4
$2M20N/AN/A
#5
$2M20N/AN/A